Iranian Journal of Child Neurology

Khalid B, Waqar Z, Khan S, Ali I, Afzal N, Irfan A, et al. Psychiatric implications of anti-seizure medications in epileptic population. BMC Neurol. 2024 May;24(1):166.

Panayiotopoulos CP. The epilepsies: seizures, syndromes and management. 2010;

Schultz AM, Strawbridge LM. Committee on the Public Health Dimensions of the Epilepsies Board on Health Sciences Policy Mary Jane England, Catharyn T. Liverman. 2012;

Momen AA, Jelodar G, Azizimalamiri R. Migraine and Epilepsy in Children: A Narrative Review of Comorbidity and Similar Treatment Option. Iran J child Neurol. 2024;18(3):9–20.

Holmes GL. Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord. 2015 Jun;17(2):101–16.

Van Rijckevorsel K. Cognitive problems related to epilepsy syndromes, especially malignant epilepsies. Seizure. 2006;15(4):227–34.

Landi S, Petrucco L, Sicca F, Ratto GM. Transient cognitive impairment in epilepsy. Front Mol Neurosci. 2019;11:458.

Helmstaedter C, Witt J-A. Epilepsy and cognition–a bidirectional relationship? Seizure. 2017;49:83–9.

Tavakoli H, Heidarpanah A. Literature Review of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Epilepsy. Iran J child Neurol. 2023;17(1):9–28.

Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology. 2012;79(13):1384–91.

Hermann B, Meador KJ, Gaillard WD, Cramer JA. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both? Epilepsy Behav. 2010;17(1):1–5.

Park S-P, Kwon S-H. Cognitive effects of antiepileptic drugs. J Clin Neurol. 2008 Sep;4(3):99–106.

Miller LA, Galioto R, Tremont G, Davis J, Bryant K, Roth J, et al. Cognitive impairment in older adults with epilepsy: characterization and risk factor analysis. Epilepsy Behav. 2016;56:113–7.

Carpay JA, Aldenkamp AP, Van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005;14(3):198–206.

Palac S, Meador KJ. Antiepileptic drugs and neurodevelopment: an update. Curr Neurol Neurosci Rep. 2011 Aug;11(4):423–7.

Martin RC, Griffith HR, Faught E, Gilliam F, Mackey M, Vogtle L. Cognitive functioning in community dwelling older adults with chronic partial epilepsy. Epilepsia. 2005;46(2):298–303.

Piazzini A, Canevini MP, Turner K, Chifari R, Canger R. Elderly people and epilepsy: cognitive function. Epilepsia (Series 4). 2006;47.

Borowicz-Reutt KK, Czuczwar SJ. Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep. 2020 Oct;72(5):1218–26.

Tedrus GMAS, Santos LM dos, Meneghetti F. Older adults with epilepsy: memory complaints and objective neuropsychological performance. Arq Neuropsiquiatr. 2021;79(2):133–8.

Hoxhaj P, Habiya SK, Sayabugari R, Balaji R, Xavier R, Ahmad A, et al. Investigating the Impact of Epilepsy on Cognitive Function: A Narrative Review. Cureus. 2023 Jun;15(6):e41223.

Wang X, Huang W, Su L, Xing Y, Jessen F, Sun Y, et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease. Mol Neurodegener. 2020;15:1–27.

Samarasekera SR, Helmstaedter C, Reuber M. Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition. Epilepsy Behav. 2015;52:9–13.

Riley JD, Franklin DL, Choi V, Kim RC, Binder DK, Cramer SC, et al. Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia. 2010;51(4):536–45.

Hermann BP, Lin JJ, Jones JE, Seidenberg M. The emerging architecture of neuropsychological impairment in epilepsy. Neurol Clin. 2009 Nov;27(4):881–907.

Nickels KC, Wirrell EC. Cognitive and social outcomes of epileptic encephalopathies. In: Seminars in pediatric neurology. Elsevier; 2017. p. 264–75.

Zhou J, Shatskikh TN, Liu X, Holmes GL. Impaired single cell firing and long‐term potentiation parallels memory impairment following recurrent seizures. Eur J Neurosci. 2007;25(12):3667–77.

Postnikova TY, Zubareva OE, Kovalenko AA, Kim KK, Magazanik LG, Zaitsev A V. Status epilepticus impairs synaptic plasticity in rat hippocampus and is followed by changes in expression of NMDA receptors. Biochem. 2017;82:282–90.

Çelik AÖ, Pınar K, Yener G, Alkin T, Öztura İ, Baklan B. Comparison of cognitive impairment between patients having epilepsy and psychogenic nonepileptic seizures. Nöro Psikiyatr Arşivi. 2015;52(2):163.

Wang L, Chen S, Liu C, Lin W, Huang H. Factors for cognitive impairment in adult epileptic patients. Brain Behav. 2020;10(1):e01475.

Gul A, Ahmad H. Thought suppression predicts task switching deficits in patients with frontal lobe epilepsy. Neurosci J. 2015;20(2):153–8.

Khalife MR, Scott RC, Hernan AE. Mechanisms for cognitive impairment in epilepsy: moving beyond seizures. Front Neurol. 2022;13:878991.

Bourgeois BFD. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol. 2004 Aug;19 Suppl 1:S15-24.

Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology. 2002;58(8_suppl_5):S21–6.

Quon RJ, Mazanec MT, Schmidt SS, Andrew AS, Roth RM, MacKenzie TA, et al. Antiepileptic drug effects on subjective and objective cognition. Epilepsy Behav. 2020 Mar;104(Pt A):106906.

Lagae L. Cognitive side effects of anti-epileptic drugs: The relevance in childhood epilepsy. Seizure [Internet]. 2006;15(4):235–41. Available from: https://www.sciencedirect.com/science/article/pii/S1059131106000392

Pal DK. Phenobarbital for childhood epilepsy: systematic review. Paediatr Perinat Drug Ther. 2006 May;7(1):31–42.

Tonekaboni SH, Beyraghi N, Tahbaz HS, Bahreynian SA, Aghamohammadpoor M. Neurocognitive effects of phenobarbital discontinuation in epileptic children. Epilepsy Behav. 2006;8(1):145–8.

Forsythe I, Butler R, Berg I, McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol. 1991;33(6):524–34.

Meador KJ, Loring DW, Abney OL, Allen ME, Moore EE, Zamrini EY, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia. 1993;34(1):153–7.

Mula M, Trimble MR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs. 2009;23(2):121–37.

Nevitt SJ, Marson AG, Weston J, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane database Syst Rev. 2017 Feb;2(2):CD001911.

Aldenkamp A, Besag F, Gobbi G, Caplan R, Dunn DW, Sillanpää M. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): adverse cognitive and behavioural effects of antiepileptic drugs in children. Epileptic Disord. 2016;18(s1):S55–67.

Aldenkamp AP, Vermeulen J. Phenytoin and carbamazepine: Differential effects on cognitive function. Seizure [Internet]. 1995;4(2):95–104. Available from: https://www.sciencedirect.com/science/article/pii/S1059131195800883

Meador KJ, Loring DW, Huh K, Gallagher BB, King DW. Comparative cognitive effects of anticonvulsants. Neurology. 1990;40(3_part_1):391.

Bromley RL, Leeman BA, Baker GA, Meador KJ. Cognitive and neurodevelopmental effects of antiepileptic drugs. Epilepsy Behav. 2011 Sep;22(1):9–16.

Ristić AJ, Vojvodić N, Janković S, Sindelić A, Sokić D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia. 2006;47(12):2183–5.

Motamedi GK, Meador KJ. Antiepileptic drugs and memory. Epilepsy Behav [Internet]. 2004;5(4):435–9. Available from: https://www.sciencedirect.com/science/article/pii/S152550500400099X

Evans MD, Shinar R, Yaari R. Reversible dementia and gait disturbance after prolonged use of valproic acid. Seizure [Internet]. 2011;20(6):509–11. Available from: https://www.sciencedirect.com/science/article/pii/S1059131111000653

Vining EPG, Mellits ED, Dorsen MM, Cataldo MF, Quaskey SA, Spielberg SP, et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics. 1987;80(2):165–74.

Sun W, Wang Y, Wang W, Wu X. Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. Int J Psychophysiol. 2008;68(3):235–41.

Gunasekera CL, Sirven JI, Feyissa AM. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time? J Cent Nerv Syst Dis. 2023;15:11795735231209208.

Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev. 2007;17:413–25.

Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia. 2003;44 Suppl 4:21–9.

Meador KJ, Gevins A, Loring DW, McEvoy LK, Ray PG, Smith ME, et al. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology. 2007;69(22):2076–84.

Neyens LG, Alpherts WC, Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(3):411–9.

Gomer B, Wagner K, Frings L, Saar J, Carius A, Härle M, et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav. 2007;10(3):486–94.

Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res. 2006;68(3):181–8.

Kossoff EH, Bergey GK, Freeman JM, Vining EPG. Levetiracetam psychosis in children with epilepsy. Epilepsia. 2001;42(12):1611–3.

Bai Y-F, Zeng C, Jia M, Xiao B. Molecular mechanisms of topiramate and its clinical value in epilepsy. Seizure [Internet]. 2022;98:51–6. Available from: https://www.sciencedirect.com/science/article/pii/S1059131122000747

Mula M, Trimble MR, Thompson P, Sander JWAS. Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003;60(7):1104–7.

Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res. 2003;54(2–3):171–8.

Ramsay RE, Uthman B, Pryor FM, Rowan AJ, Bainbridge J, Spitz M, et al. Topiramate in older patients with partial‐onset seizures: a pilot double‐blind, dose‐comparison study. Epilepsia. 2008;49(7):1180–5.

Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J, Sinclair K, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. 1999;52(2):321.

Fröscher W, Schier KR, Hoffmann M, Meyer A, May TW, Rambeck B, et al. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disord. 2005;7(3):237–48.

Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 2005 May;6(3):373–81.

Jung K-Y, Cho J-W, Joo EY, Kim SH, Choi KM, Chin J, et al. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2010 Sep;121(9):1494–501.

Coppola G, Verrotti A, Resicato G, Ferrarelli S, Auricchio G, Operto FF, et al. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav. 2008 Feb;12(2):253–6.

Blum D, Meador K, Biton V, Fakhoury T, Shneker B, Chung S, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology. 2006 Aug;67(3):400–6.

Lee H-W, Jung D-K, Suh C-K, Kwon S-H, Park S-P. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy Behav. 2006 Jun;8(4):736–41.

Aldenkamp AP, Baker G. A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life. Epilepsy Behav [Internet]. 2001;2(2):85–91. Available from: https://www.sciencedirect.com/science/article/pii/S1525505001901684

Meador KJ, Loring DW, Ray PG, Murro AM, King DW, Perrine KR, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. 2001 May;56(9):1177–82.

Placidi F, Marciani MG, Diomedi M, Scalise A, Pauri F, Giacomini P, et al. Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurol Scand. 2000 Aug;102(2):81–6.

Beran RG, Gibson RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia. 1998 Mar;39(3):280–2.

Eriksson AS, Knutsson E, Nergårdh A. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy. Epilepsia. 2001 Feb;42(2):230–6.

Nolan SJ, Tudur Smith C, Weston J, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane database Syst Rev. 2016 Nov;11(11):CD001031.

Shafiyev J, Karadaş Ö. The assessment of the impact of antiepileptic drugs on cognitive functions via N-200/P-300 potentials and neuropsychological measures. Neurol Sci [Internet]. 2024; Available from: https://doi.org/10.1007/s10072-024-07606-5

Kälviäinen R, Aikiä M, Saukkonen AM, Mervaala E, Riekkinen PJS. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. Arch Neurol. 1995 Oct;52(10):989–96.

Aikiä M, Kälviäinen R, Sivenius J, Halonen T, Riekkinen PJ. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res. 1992 May;11(3):199–203.

Salinsky MC, Spencer DC, Oken BS, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav. 2004 Dec;5(6):894–902.

Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, et al. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology. 2006 Aug;67(4):679–82.

Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 2007 Dec;16(8):670–9.

Sabers A, Møller A, Dam M, Smed A, Arlien-Søborg P, Buchman J, et al. Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol Scand. 1995 Jul;92(1):19–27.

Serdaroglu G, Kurul S, Tutuncuoglu S, Dirik E, Sarioglu B. Oxcarbazepine in the treatment of childhood epilepsy. Pediatr Neurol. 2003 Jan;28(1):37–41.

Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology. 1993 Dec;43(12):2501–7.

Wheless JW, Ramsay RE, Collins SD. Vigabatrin. Neurother J Am Soc Exp Neurother. 2007 Jan;4(1):163–72.

Vanhatalo S, Nousiainen I, Eriksson K, Rantala H, Vainionpää L, Mustonen K, et al. Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia. 2002 Jul;43(7):748–56.

Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology. 1997 Apr;48(4):1025–31.

Kälviäinen R, Aikiä M, Mervaala E, Saukkonen AM, Pitkänen A, Riekkinen PJS. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res. 1996 Nov;25(3):291–7.

Dodrill CB, Arnett JL, Deaton R, Lenz GT, Sommerville KW. Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. Epilepsy Res. 2000 Dec;42(2–3):123–32.

Aikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy Behav. 2006 Jun;8(4):750–5.

Äikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy Behav. 2006;8(4):750–5.

Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD. Epilepsy treatment in adults and adolescents: Expert opinion, 2016. Epilepsy Behav. 2017 Apr;69:186–222.

Sayed NM, Aldin MTK, Ali SE, Hendi AE. Cognitive functions and epilepsy-related characteristics in patients with generalized tonic–clonic epilepsy: a cross-sectional study. Middle East Curr Psychiatry [Internet]. 2023;30(1):15. Available from: https://doi.org/10.1186/s43045-023-00293-6

Novak A, Vizjak K, Rakusa M. Cognitive impairment in people with epilepsy. J Clin Med. 2022;11(1):267.

Leeman-Markowski BA, Schachter SC. Treatment of Cognitive Deficits in Epilepsy. Neurol Clin. 2016 Feb;34(1):183–204.

Witt J-A, Elger CE, Helmstaedter C. Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters. Eur Neuropsychopharmacol. 2015;25(11):1954–9.

Nevitt SJ, Tudur Smith C, Weston J, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane database Syst Rev. 2018 Jun;6(6):CD001031.

Foster E, Malpas CB, Ye K, Johnstone B, Carney PW, Velakoulis D, et al. Antiepileptic drugs are not independently associated with cognitive dysfunction. Neurology [Internet]. 2020;94(10):e1051–61. Available from: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000009061

Witt J-A, Helmstaedter C. How can we overcome neuropsychological adverse effects of antiepileptic drugs? Expert Opin Pharmacother. 2017 Apr;18(6):551–4.

Martin RC. AEDs and Cognition: One Small Fish in a Very Large Pond? Epilepsy Curr. 2020;20(4):196–8.

Bromley RL, Baker GA, Meador KJ. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol. 2009 Apr;22(2):162–6.

Singh R, Kumari R, T P. Clinical spectrum and neuroimaging findings in children with seizures: A five-year retrospective study. Iran J child Neurol. 2022;16(3):157–66.

Mohammadi M, Shervin Badv R, Rezaei Z, Ashrafi M, Naeemi F. The Value of Long-term Video EEG Monitoring to Diagnose and Track Childhood Epilepsy. Iran J child Neurol. 2024;18(1):9–16.